Abstract
The purpose of this TriMark Publications report is to describe the threatening
world pandemic caused by avian influenza, also known as bird flu. This report
discusses the origins of the disease, the bird-to-human infection risks, the
catastrophic health crisis avian flu poses, and the efforts by world
governments and international health organizations to mitigate of the impact
the threat to humans. The U.S., Asia and Europe are the focus of this study.
Primary attention is paid to the clinical market segment and, separately, to
the medical procedures and supplies for the influenza infection control
market. An analysis of the technology trends and developing areas of influenza
infection science is provided, along with a review of the market for
pharmaceutical agents, vaccines and hospital supplies in clinical use.
Activity in research-including the factors that influence infection
control-are addressed in this review. Also discussed are changes that have
stimulated this disease and patterns of information processing in assessing
its spread. Several subjects related to the major elements of influenza
treatment such as disposable plastic supplies, needles and lancets are
discussed only briefly because they are considered entirely different fields
or markets. The goal of this report is to review the potential threat of a
human influenza pandemic resulting from the avian flu virus. It defines the
responses that are now being undertaken worldwide by governmental authorities
to contain the spreading bird flu.
|